GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,084,000 | -49.6% | 9,610 | -73.2% | 0.00% | -57.1% |
| Q4 2020 | $4,132,000 | -5.1% | 35,799 | -19.9% | 0.01% | -50.0% |
| Q3 2020 | $4,353,000 | +30.7% | 44,719 | +64.8% | 0.01% | -6.7% |
| Q2 2020 | $3,331,000 | +15.8% | 27,141 | -17.4% | 0.02% | -34.8% |
| Q1 2020 | $2,877,000 | -24.5% | 32,854 | -9.9% | 0.02% | -11.5% |
| Q4 2019 | $3,813,000 | +63.5% | 36,468 | +79.9% | 0.03% | +36.8% |
| Q3 2019 | $2,332,000 | +48.3% | 20,273 | +122.2% | 0.02% | +35.7% |
| Q2 2019 | $1,573,000 | +702.6% | 9,125 | +354.4% | 0.01% | +600.0% |
| Q4 2018 | $196,000 | -74.3% | 2,008 | -63.2% | 0.00% | -71.4% |
| Q2 2018 | $762,000 | +45.7% | 5,463 | +17.8% | 0.01% | +40.0% |
| Q1 2018 | $523,000 | -78.9% | 4,638 | -81.0% | 0.01% | -77.3% |
| Q3 2017 | $2,473,000 | -23.0% | 24,366 | -24.0% | 0.02% | -33.3% |
| Q2 2017 | $3,212,000 | -29.9% | 32,040 | -15.4% | 0.03% | -37.7% |
| Q1 2017 | $4,581,000 | +587.8% | 37,882 | +535.5% | 0.05% | +783.3% |
| Q4 2016 | $666,000 | -50.3% | 5,961 | -59.2% | 0.01% | -62.5% |
| Q2 2016 | $1,339,000 | +2059.7% | 14,625 | +2784.6% | 0.02% | +1500.0% |
| Q2 2015 | $62,000 | -83.7% | 507 | -91.0% | 0.00% | -83.3% |
| Q4 2014 | $381,000 | -67.5% | 5,631 | -61.1% | 0.01% | -66.7% |
| Q3 2014 | $1,171,000 | -32.6% | 14,485 | -10.5% | 0.02% | -33.3% |
| Q2 2014 | $1,737,000 | +999.4% | 16,187 | +507.4% | 0.03% | +800.0% |
| Q1 2014 | $158,000 | – | 2,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|